These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37877513)

  • 1. Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy.
    Broccia G; Carter J; Ozsin-Ozler C; De Matteis S; Cocco P
    Cancer Control; 2023; 30():10732748231202906. PubMed ID: 37877513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
    Maynadié M; Girodon F; Manivet-Janoray I; Mounier M; Mugneret F; Bailly F; Favre B; Caillot D; Petrella T; Flesch M; Carli PM
    Haematologica; 2011 Jan; 96(1):55-61. PubMed ID: 20971817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired infections and their association with myeloid malignancies.
    Titmarsh GJ; McMullin MF; McShane CM; Clarke M; Engels EA; Anderson LA
    Cancer Epidemiol; 2014 Feb; 38(1):56-61. PubMed ID: 24275260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes.
    Goldin LR; Kristinsson SY; Liang XS; Derolf AR; Landgren O; Björkholm M
    J Clin Oncol; 2012 Jan; 30(2):179-83. PubMed ID: 22162584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, survival and prevalence of myeloid malignancies in Europe.
    Visser O; Trama A; Maynadié M; Stiller C; Marcos-Gragera R; De Angelis R; Mallone S; Tereanu C; Allemani C; Ricardi U; Schouten HC;
    Eur J Cancer; 2012 Nov; 48(17):3257-66. PubMed ID: 22770878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
    Polednak AP
    J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic malignancies following immune checkpoint inhibition for solid tumors.
    van Eijs MJM; van der Wagen LE; Mous R; Leguit RJ; van de Corput L; van Lindert ASR; Suelmann BBM; Kamphuis AM; Nierkens S; Suijkerbuijk KPM
    Cancer Immunol Immunother; 2023 Jan; 72(1):249-255. PubMed ID: 35691988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study.
    Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Guàrdia R; Marcos-Gragera R
    Leuk Lymphoma; 2015 Apr; 56(4):896-902. PubMed ID: 25058372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic and border differences on blood cancer presentation and outcomes: A Texas population-based study.
    Bencomo-Alvarez AE; Gonzalez MA; Rubio AJ; Olivas IM; Lara JJ; Padilla O; Orazi A; Corral J; Philipovskiy A; Gaur S; Mulla ZD; Dwivedi AK; Eiring AM
    Cancer; 2021 Apr; 127(7):1068-1079. PubMed ID: 33616915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic epigenetics: an emerging clinical approach to hematologic malignancies.
    Clin Adv Hematol Oncol; 2005 Mar; 3(3 Suppl 1):1-10; quiz 11-2. PubMed ID: 21438190
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiology of Chronic Lymphocytic Leukemia in Sardinia, Italy (1974-2003).
    Broccia G; Carter J; Ozsin-Ozler C; De Matteis S; Cocco P
    Exp Hematol; 2023; 125-126():37-44. PubMed ID: 37567460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of myeloid malignancies by subtype in Hong Kong and comparisons with Asian and white men and women in the United States.
    Bassig BA; Hu W; Morton LM; Ji BT; Xu J; Linet MS; Kwong YL; Rothman N; Wong KF; Lan Q
    Leuk Lymphoma; 2022 Aug; 63(8):1917-1924. PubMed ID: 35412943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underreporting of myeloid malignancies by United States cancer registries.
    Craig BM; Rollison DE; List AF; Cogle CR
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):474-81. PubMed ID: 22237987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
    Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis.
    Schnatter AR; Glass DC; Tang G; Irons RD; Rushton L
    J Natl Cancer Inst; 2012 Nov; 104(22):1724-37. PubMed ID: 23111193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in myeloid malignancies.
    Gordon JE; Wong JJ; Rasko JE
    Br J Haematol; 2013 Jul; 162(2):162-76. PubMed ID: 23679825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
    Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
    Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries.
    Solans M; Sanvisens A; Ameijide A; Merino S; Rojas D; Alemán A; Banqueri E; Chico M; Marcos AI; de Castro V; Gil L; de Munain AL; Puigdemont M; Sánchez MJ; Perucha J; Ruiz-Armengol P; Chirlaque MD; Guevara M; Carulla M; Marcos-Gragera R
    Sci Rep; 2022 Jan; 12(1):323. PubMed ID: 35013373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.